SUPRAME
Immatics Advances Melanoma T-Cell Therapy into Late-Stage Clinical Trials
Immatics, melanoma, T-cell therapy, ACTengine IMA203, late-stage clinical trials, SUPRAME Phase 3 trial
Actionable Insights Powered by AI
Immatics, melanoma, T-cell therapy, ACTengine IMA203, late-stage clinical trials, SUPRAME Phase 3 trial